Amatoxin Intoxication and Wild Mushroom Poisoning: Current Advances in Diagnosis, Risk Stratification, and Clinical Management
Tsonka Dimitrova, Djeni Cherneva, Kaloyan Mihalev, Ivelin Iliev, Galina Yaneva, Svetlana Georgieva · 2026
Read Amatoxin Intoxication and Wild Mushroom Poisoning: Current Advances in Diagnosis, Risk Stratification, and Clinical Management by Tsonka Dimitrova, Djeni Cherneva, Kaloyan Mihalev, Ivelin Iliev, Galina Yaneva, Svetlana Georgieva (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13211627.txt.
Description
Tsonka Dimitrova and co-authors review the state of care for wild mushroom poisoning, centering on the deadliest toxins, the amatoxins. Mushroom poisoning is hard to manage because the toxins vary, the symptoms sprawl, and liver or kidney failure can build quietly. The first clinical challenge is telling a passing stomach upset from a poisoning that will destroy organs days later.
Diagnosis is moving past symptoms alone. Modern reviews combine bedside judgment with lab markers, toxin tests, and even DNA-based identification of the mushroom species. Care has likewise become a bundle: intensive support, targeted drugs, blood-cleaning procedures, and liver transplant for the worst cases. Outcomes hinge on the toxin involved and on how fast the team acts. The authors fold in other mushroom syndromes to sharpen the comparisons that guide those first decisions.
Catalog record
| CREATOR | Tsonka Dimitrova, Djeni Cherneva, Kaloyan Mihalev, Ivelin Iliev, Galina Yaneva, Svetlana Georgieva |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 88 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |